Cost–Benefit Analysis for Genomic Services

A PhD research-backed decision support system for hospitals and diagnostic laboratories.

GenomicsCBA helps healthcare providers evaluate the financial feasibility of offering genomic services using a structured, evidence-based cost–benefit framework.

The Problem

Genomic services require significant investment in:

  • • Sequencing instruments
  • • Bioinformatics infrastructure
  • • Skilled manpower
  • • Regulatory compliance

Hospitals and laboratories struggle to answer:

  • • Is this financially viable?
  • • What is the return on investment?
  • • How long will it take to recover costs?

There is no standardized framework to evaluate these decisions systematically.

The Solution – GenomicsCBA

GenomicsCBA is a structured decision-support platform developed as part of a PhD research project.

It provides:

  • • Standardized cost categories
  • • Evidence-based assumptions
  • • Six validated base models
  • • Economic evaluation metrics

The framework is grounded in:

  • • Literature review
  • • Real-world lab workflows
  • • Practical healthcare economics
Dashboard View
Results Table
ROI
NPV
BCR
24%
₹450K
1.8

How It Works

1

Select your lab type and scale

2

Enter cost inputs

3

Enter benefit assumptions

4

View economic results

What You Can Analyze

  • • Total investment required
  • • Operating costs
  • • Expected revenue
  • • Net benefit
  • • Benefit–Cost Ratio (BCR)
  • • Net Present Value (NPV)
  • • Return on Investment (ROI)
  • • Payback period
Dashboard Charts
Tables
Category
Value
Equipment
₹250K
Personnel
₹180K
Operating
₹120K
Total
₹550K
Result Graphs

Who Should Use This?

Hospitals

Laboratories

Policymakers

Researchers

Start Your Analysis

Explore the model and understand the economics of genomic services in your organization.